The New Drug Certificate and Manufacture License of a new photodynamic drug, Aminolevulinic acid （ALA）, was issued by SFDA on 14th, Feb. 2007. The sales have started since May, 2007. The successfully marketing for ALA provided a new therapeutic way for the treatment of condyloma acuminatum (condyloma), and overcame the difficulties existing in the treatment for condyloma infected on meatus urinarius. The method is expected to be the first choice for the treatment.